ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978